IIM
FLGT icon

INTECH Investment Management’s Fulgent Genetics FLGT Stock Holding History

INTECH Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,261
Closed -$243K – 2201
2025
Q4 		$243K Sell
9,261
-1,053
-10% -$27.3K ﹤0.01% 1872
2025
Q3 		$233K Sell
10,314
-3,394
-25% -$69.9K ﹤0.01% 1975
2025
Q2 		$273K Sell
13,708
-3,151
-19% -$61.4K ﹤0.01% 1921
2025
Q1 		$285K Sell
16,859
-26,680
-61% -$454K ﹤0.01% 1920
2024
Q4 		$804K Buy
43,539
+31,037
+248% +$606K 0.01% 1282
2024
Q3 		$272K Buy
+12,502
New +$280K ﹤0.01% 1566

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

INTECH Investment Management's FLGT Position: Q1 2026 in Review

INTECH Investment Management sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 9,261 shares — an estimated $243K sold.

INTECH Investment Management first reported a position in FLGT in Q3 2024 and held it in 6 quarters. The position peaked at $804K in Q4 2024. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • INTECH Investment Management reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • INTECH Investment Management sold 9,261 Fulgent Genetics shares in Q1 2026, an estimated $243K.
  • INTECH Investment Management first reported a position in Fulgent Genetics in Q3 2024 and held it in 6 quarters.
  • INTECH Investment Management's Fulgent Genetics position peaked at $804K in Q4 2024.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on INTECH Investment Management's 13F filing for Q1 2026, filed 8 May 2026.